Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Internal Medicine Journal
|
September 6, 2012
Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease
N A Kennedy, T L Asser, R E Mountifield, et al.
Alimentary Pharmacology & Therapeutics
|
November 11, 2011
Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000
N A Kennedy, D N Clark, J Bauer, et al.
Gut
|
December 6, 2014
MicroRNAs: new players in IBD
R Kalla, N T Ventham, N A Kennedy, et al.
Alimentary Pharmacology & Therapeutics
|
October 15, 2013
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis
N A Kennedy, E Rhatigan, I D R Arnott, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2014
Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998-2000 and 2007-2009
N T Ventham, N A Kennedy, A Duffy, et al.
Journal of Crohn'S & Colitis
|
November 20, 2018
Faecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn's Disease: Correlations Between Disease Activity and Long-Term Follow-Up
G R Jones, F Fascì-Spurio, N A Kennedy, et al.
Alimentary Pharmacology & Therapeutics
|
January 21, 2017
Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease
N Heerasing, B Thompson, P Hendy, et al.
Nature Communications
|
November 26, 2016
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
N T Ventham, N A Kennedy, A T Adams, et al.
Alimentary Pharmacology & Therapeutics
|
March 7, 2018
Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study
G J Walker, L Moore, N Heerasing, et al.
Mucosal Immunology
|
April 13, 2017
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation
G-T Ho, R E Aird, B Liu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Internal Medicine Journal
|
September 6, 2012
Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease
N A Kennedy, T L Asser, R E Mountifield, et al.
Alimentary Pharmacology & Therapeutics
|
November 11, 2011
Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000
N A Kennedy, D N Clark, J Bauer, et al.
Gut
|
December 6, 2014
MicroRNAs: new players in IBD
R Kalla, N T Ventham, N A Kennedy, et al.
Alimentary Pharmacology & Therapeutics
|
October 15, 2013
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis
N A Kennedy, E Rhatigan, I D R Arnott, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2014
Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998-2000 and 2007-2009
N T Ventham, N A Kennedy, A Duffy, et al.
Journal of Crohn'S & Colitis
|
November 20, 2018
Faecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn's Disease: Correlations Between Disease Activity and Long-Term Follow-Up
G R Jones, F Fascì-Spurio, N A Kennedy, et al.
Alimentary Pharmacology & Therapeutics
|
January 21, 2017
Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease
N Heerasing, B Thompson, P Hendy, et al.
Nature Communications
|
November 26, 2016
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
N T Ventham, N A Kennedy, A T Adams, et al.
Alimentary Pharmacology & Therapeutics
|
March 7, 2018
Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study
G J Walker, L Moore, N Heerasing, et al.
Mucosal Immunology
|
April 13, 2017
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation
G-T Ho, R E Aird, B Liu, et al.
Page
of 3